CLINICALLY ISOLATED SYNDROME
Clinical trials for CLINICALLY ISOLATED SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY ISOLATED SYNDROME trials appear
Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can diet and exercise rival MS drugs? new study investigates
Disease control OngoingThis study aims to find out if a comprehensive lifestyle program—including a specific diet, exercise, and stress reduction—can be as effective as standard drug treatments for people newly diagnosed with multiple sclerosis (MS) or its early stage (CIS). It follows 44 participants …
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: NA • Sponsor: Terry L. Wahls • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early MS drug test aims to stop brain damage before it starts
Disease control OngoingThis study is testing whether starting a medication called ocrelizumab very early after MS symptoms first appear can change signs of ongoing inflammation in the fluid around the brain and spinal cord. Researchers will treat 30 newly diagnosed adults and measure specific markers i…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
AI brain scan analysis tested to spot hidden MS progression
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether using artificial intelligence (AI) software to analyze brain MRI scans helps doctors better detect disease activity in people with multiple sclerosis (MS). It will compare 750 patients whose doctors use the AI tool with those who receive standard car…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: NA • Sponsor: icometrix • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC